
Results in Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 105047 - 105047
Published: April 1, 2025
Language: Английский
Results in Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 105047 - 105047
Published: April 1, 2025
Language: Английский
Diagnostics, Journal Year: 2025, Volume and Issue: 15(3), P. 397 - 397
Published: Feb. 6, 2025
Radioimmunotherapy (RIT) is a novel cancer treatment that combines radiotherapy and immunotherapy to precisely target tumor antigens using monoclonal antibodies conjugated with radioactive isotopes. This approach offers personalized, systemic, durable treatment, making it effective in cancers resistant conventional therapies. Advances artificial intelligence (AI) present opportunities enhance RIT by improving precision, efficiency, personalization. AI plays critical role patient selection, planning, dosimetry, response assessment, while also contributing drug design classification. review explores the integration of into RIT, emphasizing its potential optimize entire process advance personalized care.
Language: Английский
Citations
3Results in Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 105047 - 105047
Published: April 1, 2025
Language: Английский
Citations
0